First annual WSU and PHP Neuroscience Institute Symposium slated for Nov. 14

Wright State University and Premier Health Partners symposium to focus on translational neuroscience

The Wright State University and Premier Health Partners Neuroscience Institute will present its first annual neuroscience institute symposium, “Selected Topics in Translational Neuroscience,” on Wednesday, Nov. 14, from 1 to 4 p.m. in the Nutter Center Berry Room on the campus of Wright State University. A reception will be held from 1 to 2 p.m. before the formal program begins at 2 p.m.

Presentations will explore the underlying mechanisms for the development of epilepsy, indications and outcomes for the surgical treatment of epilepsy, the interventional treatment options for acute stroke management and the mechanism of neurological involvement in critical illness.

The presentations include:

Genetic Epilepsies and GABAA Receptor Mutations
Robert L. Macdonald, M.D., Ph.D.
Professor and Chair of Neurology
Professor of Molecular Physiology and Biophysics
Professor of Pharmacology
Vanderbilt University School of Medicine

Clinical Perspectives in Epilepsy Surgery
Jeffrey Stephen Schweitzer, M.D., Ph.D.
Director, Stereotactic and Functional Neurosurgery Program
Kaiser Permanente Los Angeles Medical Center

Interventional Management of Stroke
Bryan Ludwig, M.D.
NeuroInterventional Specialists Inc.
Director of NeuroInterventional Radiology
Miami Valley Hospital/Premier Health Partners
Premier Health Specialists Inc.
Clinical Assistant Professor
Department of Neurology
Wright State University Boonshoft School of Medicine

Ion Channel Dysfunction During Critical Illness
Mark Rich, M.D., Ph.D.
Professor, Neuroscience, Cell Biology and Physiology
Professor, Neurology
Wright State University Boonshoft School of Medicine

Launched in 2010, the Wright State University and Premier Health Partners Neuroscience Institute represents a groundbreaking collaboration that leverages some of the Dayton region’s greatest strengths to address many of its most crucial needs. Designated as a University System of Ohio Center of Excellence, this public-private partnership unites the region’s most advanced biomedical research institution with the clinical resources of its leading hospital system.

Ken Gaines, M.D., M.B.A., has been recruited to serve as institute codirector and to lead the institute’s new team of clinical neurologists. A subspecialist in vascular neurology, Gaines came to the Neuroscience Institute from the Ochsner Clinic and Foundation in New Orleans, where he served as chair of the Department of Neurology.

Gaines joins director Tim Cope, Ph.D., Brage Golding Distinguished Professor of Research and chair of the Department of Neuroscience, Cell Biology and Physiology, who oversaw the founding of the institute. Together they are building a team of active physicians, scientists and neurologists who will help to drive the institute’s interactive research.

For more information or to register, go to


Comments are closed.